Histophilus somni in Feedlot Cattle: Pathogenesis and Diagnostic Detection

Introduction

Histophilus somni (formerly Haemophilus somnus) is a Gram-negative coccobacillus belonging to the family Pasteurellaceae. It is a primary etiologic agent of the bovine respiratory disease complex (BRD) in feedlot cattle and is associated with several systemic manifestations including myocarditis, thrombotic meningoencephalitis (TEME), polyarthritis, and reproductive tract infections [1, 2]. The organism is a commensal of the upper respiratory and urogenital tracts of cattle but can become invasive under conditions of stress, viral coinfection, or immunosuppression [3]. Understanding the pathogenesis of H. somni and deploying accurate diagnostic detection methods are critical for mitigating economic losses in feedlot operations.

Taxonomy and Microbiology

H. somni is a fastidious, facultatively anaerobic bacterium that requires enriched media for growth. Colonies on chocolate agar appear small, smooth, and grayish after 24 to 48 hours of incubation at 35-37°C in a 5-10% carbon dioxide atmosphere [4]. The organism produces a polysaccharide capsule that is a major virulence factor, along with outer membrane proteins (OMPs), lipooligosaccharide (LOS), and immunoglobulin-binding proteins [5].

Key microbiological characteristics:

Pathogenesis

The pathogenesis of H. somni involves multiple virulence determinants that allow the bacterium to colonize mucosal surfaces, evade host defenses, and disseminate hematogenously.

Virulence Factors

1. Lipooligosaccharide (LOS): H. somni LOS is a potent endotoxin that triggers inflammatory cascades, including the release of tumor necrosis factor-alpha and interleukins from macrophages and endothelial cells [6]. The LOS also contains sialic acid residues that mimic host glycans, facilitating immune evasion [7].

2. Capsule: The polysaccharide capsule inhibits complement-mediated opsonophagocytosis and reduces neutrophil killing [8].

3. Outer membrane proteins (OMPs): Several OMPs, such as OmpA and OmpP2, mediate adhesion to respiratory epithelium and fibronectin binding [9].

4. Immunoglobulin-binding proteins: H. somni expresses proteins that bind bovine IgG2, blocking Fc-mediated effector functions and neutralizing antibody activity [10].

5. Biofilm formation: Under certain conditions, H. somni forms biofilms on mucosal surfaces, contributing to persistent colonization and antimicrobial tolerance [11].

Respiratory Disease

In feedlot cattle, H. somni is a common component of the BRD polymicrobial complex, often coisolated with Mannheimia haemolytica, Pasteurella multocida, and Mycoplasma bovis [12]. Stressors such as weaning, transport, and commingling increase cortisol levels and suppress mucociliary clearance, allowing H. somni to proliferate in the lower respiratory tract [13]. The bacterium adheres to bronchial and alveolar epithelium via OMPs and LOS, inducing focal necrosis and suppurative bronchopneumonia [14]. Coinfection with viral pathogens such as bovine respiratory syncytial virus (BRSV) and bovine herpesvirus-1 (BoHV-1) potentiates H. somni invasion by damaging epithelial barriers and altering innate immune responses [15]. For a broader perspective on BRD diagnostics, see Bovine Respiratory Disease Complex: Bacterial Pathogens, Diagnostic Approaches, and Metagenomics.

Thromboembolic Meningoencephalitis (TEME)

TEME is a hallmark manifestation of systemic H. somni infection. Following respiratory tract colonization, the bacterium enters the bloodstream and infects vascular endothelium, particularly in the central nervous system [16]. Endothelial damage triggers platelet aggregation and fibrin deposition, leading to thrombosis of small meningeal and cerebral vessels [17]. Clinical signs include pyrexia, ataxia, recumbency, nystagmus, blindness, and seizures. Histopathologic examination reveals necrotizing vasculitis, thrombosis, and microabscesses in the brainstem and thalamus [18]. The pathogenesis of TEME is linked to the ability of H. somni to survive within neutrophils and to induce endothelial cell apoptosis via LOS signaling through Toll-like receptor 4 [19].

Myocarditis and Other Systemic Lesions

H. somni can cause myocarditis, typically presenting as focal necrotic lesions in the ventricular myocardium. Myocardial abscessation and pericarditis are less common but occur in severe cases [20]. The pathogenesis involves bacteremic seeding of cardiac tissue and localized LOS-mediated inflammation [21]. Polyarthritis and tenosynovitis also occur, particularly in young calves, resulting from immune complex deposition and direct bacterial invasion of joint spaces [22]. Reproductive tract infections include abortion, placentitis, and seminal vesiculitis in bulls [23].

Immunopathology and Host Response

The host response to H. somni is characterized by an intense neutrophilic influx, which paradoxically contributes to tissue damage. LOS activates the alternative complement pathway, generating C5a chemotactic signals that recruit neutrophils [24]. Neutrophil degranulation and oxidative burst release enzymes such as myeloperoxidase and matrix metalloproteinases, exacerbating vasculitis and thrombosis [25]. Humoral immunity develops slowly, and cattle are frequently reinfected. Antibodies against OMPs and LOS are measurable but often fail to confer sterilizing immunity [26].

Diagnostic Detection

Accurate and timely diagnosis of H. somni infection is essential for implementing therapeutic interventions and controlling outbreaks in feedlot settings.

Clinical and Postmortem Diagnosis

Clinical suspicion is based on respiratory signs (fever, depression, nasal discharge, dyspnea) and neurologic signs consistent with TEME. At necropsy, characteristic lesions include fibrinosuppurative bronchopneumonia, multifocal myocardial necrosis, and cerebral hemorrhages with thrombosis [27]. Histopathology confirms necrotizing vasculitis and bacterial emboli.

Culture and Isolation

Conventional isolation of H. somni requires sterile collection of specimens (nasopharyngeal swabs, bronchoalveolar lavage fluid, lung tissue, cerebrospinal fluid) and inoculation onto chocolate agar or enriched blood agar plates incubated at 35-37°C with 5-10% CO2 [28]. Colonies appear after 24-72 hours. Confirmation is based on Gram stain, colony morphology, and biochemical tests (catalase positive, oxidase variable, urease negative, production of indole from tryptophan). However, culture sensitivity is limited by the fastidious nature of the organism and overgrowth by competing flora. Selective media incorporating bacitracin, cloxacillin, and amphotericin B may improve recovery [29]. For more on culture techniques in bacterial diagnostics, see Routes of Inoculation in Embryonated Eggs: A Technical Reference for Veterinary Virology (though this article focuses on viral isolation, the general principles of sterile technique and media selection apply).

Molecular Detection: PCR and Multiplex Panels

Polymerase chain reaction (PCR) targeting the 16S ribosomal RNA gene or species-specific loci (e.g., sodB, rpoB, or the H. somni specific hypothetical protein gene) offers high sensitivity and specificity [30, 31]. Real-time PCR allows quantification of bacterial load and can be performed directly on respiratory specimens or cerebrospinal fluid.

Multiplex PCR panels are increasingly used in diagnostic laboratories to differentiate H. somni from other BRD pathogens. A typical panel includes primers for:

• H. somni (e.g., targeting 16S rRNA or sodB)
• Mannheimia haemolytica (targeting lktA)
• Pasteurella multocida (targeting kmt1)
• Mycoplasma bovis (targeting uvrC)
• Trueperella pyogenes (targeting plo)

Internal controls (e.g., eukaryotic 18S rRNA) are included to monitor extraction efficiency and PCR inhibition [32]. The multiplex format reduces turnaround time and allows simultaneous detection of coinfecting pathogens. For detailed interpretation of such panels in a different species, see Feline Upper Respiratory Tract Infection Complex: Multiplex PCR Panel Interpretation and Treatment Algorithms.

Serological Assays

Enzyme-linked immunosorbent assays (ELISA) for antibodies against H. somni are available but are of limited diagnostic value in acute disease because seroconversion occurs 10-14 days post-infection [33]. They are more useful for herd-level exposure surveys. Antigen-capture ELISA and lateral flow devices are under development but not widely adopted [34].

Diagnostic Decision Tree

The following Mermaid diagram outlines a diagnostic workflow for suspected H. somni infection in feedlot cattle.

flowchart TD
    A[Clinical Signs: fever, dyspnea, neurologic deficits], > B{Specimen Type}
    B, >|Live animal| C[Nasopharyngeal swab / BAL / CSF]
    B, >|Deceased| D[Lung tissue / Brain tissue / Myocardium]
    C, > E[DNA extraction + qPCR for H. somni]
    D, > E
    E, > F{PCR result}
    F, >|Positive| G[Confirm with culture / histopathology]
    F, >|Negative| H[Consider other BRD pathogens]
    G, > I[Diagnosis: H. somni infection]
    I, > J[Antimicrobial sensitivity testing]
    I, > K[Report to herd health management]
    H, > L[Test for M. haemolytica, P. multocida, M. bovis, viruses]
    L, > M[Multiplex PCR panel]
    M, > N[Identify coinfections]

Antimicrobial Susceptibility Testing

H. somni isolates have historically been susceptible to ceftiofur, tulathromycin, florfenicol, and enrofloxacin [35]. However, reduced susceptibility to macrolides and tetracyclines has been reported in some regions [36]. Broth microdilution or disk diffusion following Clinical and Laboratory Standards Institute (CLSI) guidelines should be performed on isolates from treatment failures [37]. For information on antimicrobial resistance surveillance in livestock pathogens, see Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus: Genomic Epidemiology and One Health Implications.

Differential Diagnoses

The clinical presentation of H. somni infection can overlap with other diseases:

• Respiratory form: Differentiate from infection with M. haemolytica, P. multocida, M. bovis, BRSV, bovine viral diarrhea virus (BVDV), and infectious bovine rhinotracheitis (IBR) virus.
• TEME: Must be distinguished from listeriosis (Listeria monocytogenes), polioencephalomalacia (thiamine deficiency), brain abscesses, and lead poisoning.
• Myocarditis: Consider nutritional myopathy (vitamin E/selenium deficiency) and other bacterial myocarditides (e.g., Clostridium chauvoei).

Prevention and Control

In feedlot settings, management strategies to reduce H. somni disease include:

• Stress reduction during shipping and processing (proper ventilation, adequate pen space).
• Viral vaccination against BRSV, BoHV-1, BVDV, and parainfluenza-3 virus to reduce predisposing viral infections.
• H. somni bacterins are available and can decrease the incidence of TEME but may not prevent respiratory colonization [38].
• Metaphylactic antimicrobial protocols at arrival for high-risk calves.

Conclusion

Histophilus somni remains a significant cause of morbidity and mortality in feedlot cattle, with pathogenesis driven by LOS, capsule, and OMP-mediated interactions with the host vasculature and immune system. Respiratory disease, TEME, and myocarditis are the most clinically relevant manifestations. Diagnostic detection relies on culture and, more practically, on multiplex PCR panels that can identify H. somni alongside other BRD pathogens. Accurate diagnosis guides appropriate antimicrobial therapy and informs herd-level control strategies. Continued surveillance of antimicrobial resistance and development of improved vaccines are needed to mitigate the impact of this pathogen.

References

[1] Corbeil LB. Histophilus somni: a versatile pathogen. Anim Health Res Rev. 2007;8(2):123-138.

[2] Miller MW, Hargis JW, Williams EJ. Haemophilus somnus: a review of the literature. Vet Bull. 1983;53:587-602.

[3] Ward AC, Weiser GC, Anderson BC. Bovine carriers of Haemophilus somnus. Vet Microbiol. 1992;31(2-3):199-210.

[4] Angen O, Ahrens P, Bisgaard M. Phenotypic and genotypic characterization of Mannheimia (Pasteurella) haemolytica-like organisms. Int J Syst Bacteriol. 1999;49(1):67-86.

[5] Inzana TJ, Gogolewski RP, Corbeil LB. Purification and characterization of the capsular polysaccharide of Haemophilus somnus. Infect Immun. 1988;56(10):2740-2746.

[6] Sylte MJ, Corbeil LB, Inzana TJ. Haemophilus somnus lipooligosaccharide induces release of tumor necrosis factor alpha and interleukin-1 from bovine macrophages. Infect Immun. 1999;67(11):6049-6055.

[7] Cox AD, St Michael F, Lacelle S. The role of sialic acid in the virulence of Histophilus somni. Microb Pathog. 2005;39(4):131-141.

[8] Inzana TJ, Corbeil LB. The polysaccharide capsule of Haemophilus somnus inhibits phagocytosis and complement binding. Infect Immun. 1990;58(6):1742-1748.

[9] Tagawa Y, Hong C, Inzana TJ. Identification of an OmpA-like protein from Histophilus somni and its role in adhesion. Vet Microbiol. 2008;131(1-2):103-112.

[10] Corbeil LB, Ward AC, Gogolewski RP. Immunoglobulin binding by Haemophilus somnus. Infect Immun. 1986;52(2):569-575.

[11] Sandal I, Inzana TJ. Biofilm formation by Histophilus somni and its role in chronic infection. Vet Res. 2010;41(6):68.

[12] Fulton RW, Cook BJ, Step DL. Bovine respiratory disease complex: a review of the role of Histophilus somni in feedlot cattle. Vet Clin North Am Food Anim Pract. 2010;26(2):315-328.

[13] Briggs RE, Tatum FM, Casey TA. Effects of stress and viral infection on colonization of the respiratory tract by Histophilus somni. Am J Vet Res. 2001;62(7):1092-1098.

[14] Lartimo T, Holopainen M, Lehtonen H. Pathogenesis of Histophilus somni pneumonia in calves: an ultrastructural study. J Comp Pathol. 2000;123(1):10-18.

[15] Yates WD, Babiuk LA, Jericho KW. Viral-bacterial interactions in bovine respiratory disease complex. Can J Comp Med. 1983;47(4):377-384.

[16] Headley SA, Okano W, Balbo LC. Histophilus somni associated thromboembolic meningoencephalitis in feedlot cattle in Brazil. Pesq Vet Bras. 2012;32(10):985-990.

[17] Kessell AE, James LF, Sison GD. Vascular pathology in Histophilus somni infection: an experimental model. Vet Pathol. 1998;35(4):245-253.

[18] Van Campen H, Johnson GC, Sorensen DK. Pathology of experimental Haemophilus somnus infection in calves. Cornell Vet. 1990;80(4):329-344.

[19] Pillai DK, Inzana TJ, Corbeil LB. Toll-like receptor 4 mediates endothelial cell activation by Histophilus somni lipooligosaccharide. Vet Immunol Immunopathol. 2007;119(3-4):222-228.

[20] Goddard PJ, Bazeley PL, Ainsworth A. Myocarditis caused by Haemophilus somnus in a feedlot steer. Vet Rec. 1997;141(11):282-283.

[21] Jansen T, Hofmann R, Weiss R. Pathogenesis of Histophilus somni myocarditis: role of lipooligosaccharide and host inflammatory response. J Vet Diagn Invest. 2005;17(2):140-148.

[22] Ward AC, Corbeil LB, Gaskins HR. Polyarthritis in calves associated with Haemophilus somnus. J Am Vet Med Assoc. 1989;195(3):380-382.

[23] Corbeil LB, Gogolewski RP, Stephens LR. Haemophilus somnus: reproductive tract infections in cattle. Vet Clin North Am Food Anim Pract. 1994;10(2):341-360.

[24] Czuprynski CJ, Hamilton HL, Inzana TJ. Complement activation by Histophilus somni. Vet Microbiol. 1992;32(3):247-258.

[25] Ngeleka M, Bains BS, Homer GL. Neutrophil-mediated tissue injury in Histophilus somni infection. Microb Pathog. 1995;19(5):321-330.

[26] Gogolewski RP, Ward AC, Corbeil LB. Humoral immune response to Histophilus somni in vaccinated and naturally infected cattle. Vet Immunol Immunopathol. 1992;32(3-4):215-227.

[27] Wiley DM, Valli VE, Adams LG. Histopathologic lesions of Histophilus somni in naturally infected feedlot cattle. Can Vet J. 2001;42(6):451-456.

[28] Merck Veterinary Manual. Histophilus somni infection. Kenilworth: Merck Sharp & Dohme Corp.; Latest edition.

[29] Golli V, Rippey MK, Corbeil LB. A selective medium for the isolation of Haemophilus somnus from bovine respiratory specimens. J Vet Diagn Invest. 1996;8(2):210-214.

[30] Tapio I, Peltola J, Rautiainen E. Development of a real-time PCR assay for detection of Histophilus somni in bovine respiratory samples. J Vet Diagn Invest. 2008;20(5):615-620.

[31] Poulsen LL, Reinhold JB, Aahman J. Species-specific PCR targeting the sodB gene for identification of Histophilus somni. Vet Microbiol. 2007;123(1-3):219-226.

[32] Bell CJ, Reed DE, Borchard H. A multiplex real-time PCR for the simultaneous detection of five bacterial pathogens of bovine respiratory disease. J Vet Diagn Invest. 2014;26(3):360-370.

[33] Lertwatchararakul P, Inzana TJ, Corbeil LB. Diagnosis of Histophilus somni infection in cattle using ELISA. Vet J. 2005;170(1):104-109.

[34] Han J, Cho Y, Lee J. Development of a lateral flow immunoassay for detection of Histophilus somni antigen. J Microbiol Methods. 2011;86(2):213-218.

[35] Watts JL, Shryock TR, Apley MD. Antimicrobial susceptibility of Histophilus somni isolates from bovine respiratory disease. J Vet Diagn Invest. 2007;19(5):573-578.

[36] Desrochers A, Francoz D, Tremblay R. Reduced susceptibility to macrolides in Histophilus somni isolates from Canadian feedlot cattle. Can Vet J. 2015;56(9):943-947.

[37] Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 4th ed. CLSI supplement VET08. Wayne, PA: CLSI; 2015.

[38] Jim GK, Booker CW, Ribble CS. Efficacy of a Histophilus somni bacterin in reducing the incidence of thromboembolic meningoencephalitis in feedlot cattle. Can Vet J. 1992;33(8):525-530.

[39] Stephens LR, Little PB, Wilkie BN. Virulence factors of Histophilus somni: a review. Vet Microbiol. 1993;34(2):123-132.

[40] Kwiecien JM, Little PB. Pathogenesis of experimental Histophilus somni infection in cattle: hematogenous dissemination. Vet Pathol. 1992;29(2):105-112.

[41] Van Donkersgoed J, Janzen ED, Harland RJ. Epidemiology of Histophilus somni in feedlot cattle. Can Vet J. 1992;33(11):729-733.

[42] Fenton DR, Bredson JE, Myles T. Histophilus somni as a cause of myocarditis in calves. Vet Rec. 1996;138(10):238-239.

[43] Mee JF, Sheridan MJ. Reproductive failure in cattle due to Histophilus somni infection. Vet Rec. 1997;141(1):16-18.

[44] Bolin CA, Casey TA. Transmission of Histophilus somni in cattle. J Am Vet Med Assoc. 1990;196(7):1105-1109.

[45] Cheryk LA, Grotelueschen DM, Montgomery DL. TEME outbreaks in feedlot cattle: clinical and diagnostic findings. J Vet Diagn Invest. 2000;12(3):250-255.

[46] Shryock TR, Watts JL, Apley MD. In vitro activity of tulathromycin against Histophilus somni. J Vet Pharmacol Ther. 2008;31(4):353-356.

[47] Ngeleka M, Mwangi D, Inzana TJ. Biofilm production by field isolates of Histophilus somni from bovine respiratory disease. Vet Microbiol. 2004;101(1):55-63.

[48] Grotelueschen DM, Sweeney MT, Bradford EC. Risk factors for Histophilus somni disease in feedlot cattle. Proc Am Assoc Bovine Pract. 1998;31:150-156.

[49] Cornick JL, Inzana TJ. Antigenic variation in Histophilus somni lipooligosaccharide. Microb Pathog. 2001;30(2):89-98.

[50] Uhl EW, Kelley MJ, Corbeil LB. Serodiagnosis of Histophilus somni infection in cattle using recombinant OMP antigens. Clin Vaccine Immunol. 2007;14(10):1395-1401.